Pills masthead

News Releases

Archives: Search / 2019 / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010

20092008200720062004

2019 Archives

Feb 6, 2019
- Recent 17 Product Launches Contributed $40 Million of Net Sales in Fiscal 2019 YTD

Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2019 second quarter ended December 31, 2018. "Stellar sales across our product offering drove our strong fiscal...

More
Feb 6, 2019
Product Launches, Cost Savings, Insulin Glargine
Jan 30, 2019

Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2019 second quarter on Wednesday, February 6, 2019, after the market closes. Lannett...

More
Jan 22, 2019
Company Has Begun Marketing Entacapone IR Tablets

Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an agreement with a strategic alliance partner to be the exclusive U.S. distributor of Trientine Hydrochloride Capsules,...

More
 
Price Data
NYSELCI